4.9349
price up icon0.51%   0.0149
 
loading
Schlusskurs vom Vortag:
$4.92
Offen:
$4.94
24-Stunden-Volumen:
493.82K
Relative Volume:
0.13
Marktkapitalisierung:
$1.17B
Einnahmen:
$251.85M
Nettoeinkommen (Verlust:
$-72.58M
KGV:
-41.12
EPS:
-0.12
Netto-Cashflow:
$-63.80M
1W Leistung:
+4.99%
1M Leistung:
-15.90%
6M Leistung:
-35.95%
1J Leistung:
+14.47%
1-Tages-Spanne:
Value
$4.82
$4.96
1-Wochen-Bereich:
Value
$4.63
$5.06
52-Wochen-Spanne:
Value
$4.06
$10.13

Ardelyx Inc Stock (ARDX) Company Profile

Name
Firmenname
Ardelyx Inc
Name
Telefon
510-745-7047
Name
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Name
Mitarbeiter
267
Name
Twitter
@ardelyx
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
ARDX's Discussions on Twitter

Vergleichen Sie ARDX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
ARDX 4.945 1.17B 251.85M -72.58M -63.80M -0.12
VRTX 447.62 115.74B 10.63B -479.80M -1.35B 13.33
REGN 742.10 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.10 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.88 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.40 24.49B 3.30B -501.07M 1.03B 11.54

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-02 Herabstufung Piper Sandler Overweight → Neutral
2024-04-05 Eingeleitet Leerink Partners Outperform
2023-12-18 Eingeleitet Raymond James Strong Buy
2023-09-07 Eingeleitet H.C. Wainwright Buy
2023-08-25 Hochstufung Cantor Fitzgerald Neutral → Overweight
2023-03-03 Hochstufung Wedbush Neutral → Outperform
2022-11-17 Hochstufung Piper Sandler Neutral → Overweight
2022-05-06 Herabstufung Cantor Fitzgerald Overweight → Neutral
2021-12-01 Hochstufung Ladenburg Thalmann Neutral → Buy
2021-10-14 Herabstufung Ladenburg Thalmann Buy → Neutral
2021-07-21 Herabstufung Jefferies Buy → Hold
2021-07-20 Herabstufung Piper Sandler Overweight → Neutral
2021-07-20 Herabstufung Wedbush Outperform → Neutral
2021-03-23 Eingeleitet Wedbush Outperform
2021-01-06 Eingeleitet Cantor Fitzgerald Overweight
2020-10-20 Fortgesetzt Citigroup Buy
2020-02-18 Fortgesetzt Jefferies Buy
2020-02-12 Eingeleitet Citigroup Buy
2020-02-10 Eingeleitet Cowen Outperform
2019-04-08 Eingeleitet Piper Jaffray Overweight
2018-08-24 Eingeleitet Jefferies Buy
2018-03-19 Fortgesetzt Leerink Partners Outperform
2017-11-29 Bestätigt Citigroup Buy
2017-11-22 Bestätigt Ladenburg Thalmann Buy
2017-10-17 Fortgesetzt Leerink Partners Outperform
2016-03-31 Eingeleitet Ladenburg Thalmann Buy
2016-03-09 Eingeleitet Cantor Fitzgerald Buy
2016-03-03 Eingeleitet Citigroup Buy
Alle ansehen

Ardelyx Inc Aktie (ARDX) Neueste Nachrichten

pulisher
Nov 20, 2024

Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Ardelyx Executives to Present at Piper Sandler Healthcare Conference | ARDX Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Jefferies optimistic on Ardelyx stock as management navigates reimbursement changes - Investing.com

Nov 20, 2024
pulisher
Nov 18, 2024

US Penny Stocks To Monitor In November 2024 - Simply Wall St

Nov 18, 2024
pulisher
Nov 18, 2024

Ardelyx, Inc. (NASDAQ:ARDX) Short Interest Up 5.1% in October - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Ardelyx, Inc. (NASDAQ:ARDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 17, 2024
pulisher
Nov 15, 2024

Ardelyx (NASDAQ:ARDX) Shares Gap UpTime to Buy? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Janus Henderson Group PLC's Strategic Reduction in Ardelyx Inc H - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Director David Mott Acquires 215,868 Shares of Ardelyx Inc (ARDX) - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability (NASDAQ:ARDX) - Seeking Alpha

Nov 14, 2024
pulisher
Nov 13, 2024

HC Wainwright Has Bearish Forecast for Ardelyx Q1 Earnings - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Ardelyx (NASDAQ:ARDX) Rating Lowered to “Neutral” at HC Wainwright - Defense World

Nov 13, 2024
pulisher
Nov 11, 2024

Ardelyx shares downgraded amid sales concerns for XPHOZAH By Investing.com - Investing.com Australia

Nov 11, 2024
pulisher
Nov 11, 2024

Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop - Seeking Alpha

Nov 11, 2024
pulisher
Nov 11, 2024

Ardelyx (NASDAQ:ARDX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Ardelyx shares downgraded amid sales concerns for XPHOZAH - Investing.com India

Nov 11, 2024
pulisher
Nov 11, 2024

Ardelyx (NASDAQ:ARDX) Lowered to Neutral Rating by HC Wainwright - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Ardelyx chief development officer sells shares worth $165,743 - Investing.com India

Nov 09, 2024
pulisher
Nov 09, 2024

Ardelyx chief development officer sells shares worth $165,743 By Investing.com - Investing.com Australia

Nov 09, 2024
pulisher
Nov 08, 2024

David P. Rosenbaum Sells 27,171 Shares of Ardelyx, Inc. (NASDAQ:ARDX) Stock - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx Beats Q3 Sales Estimates, Shares Climb - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx Loses Bid to Block HHS Classification of Kidney Drug - Bloomberg Law

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx tumbles as lawsuit against CMS dismissed over Xphozah (update) - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx Responds to District Court Decision Granting Motion to Dismiss - The Manila Times

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx (NASDAQ:ARDX) Shares Gap DownTime to Sell? - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx ‘disappointed’ by court decision granting motion to dismiss - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx Stock Alert: Court Dismisses CMS Lawsuit, XPHOZAH Access Concerns Mount | ARDX Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx falls after court dismisses lawsuit against CMS over company's kidney disease drug - XM

Nov 08, 2024
pulisher
Nov 06, 2024

Ardelyx chief development officer sells $161,673 in stock - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Ardelyx chief development officer sells $161,673 in stock By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

(ARDX) Investment Analysis - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 06, 2024

Citigroup Lowers Ardelyx (NASDAQ:ARDX) Price Target to $10.00 - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference - ForexTV.com

Nov 05, 2024
pulisher
Nov 05, 2024

Ardelyx (ARDX) Leadership to Present at Jefferies London Healthcare Conference 2024 | ARDX Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

What is Wedbush’s Forecast for Ardelyx FY2026 Earnings? - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Inve - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Ardelyx (NASDAQ:ARDX) Price Target Lowered to $10.00 at Citigroup - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Wedbush Has Negative Outlook for Ardelyx FY2026 Earnings - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Ardelyx, Inc. (NASDAQ:ARDX) Q3 2024 Earnings Call Transcript - MSN

Nov 03, 2024
pulisher
Nov 03, 2024

Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Simply Wall St

Nov 03, 2024
pulisher
Nov 03, 2024

Ardelyx (NASDAQ:ARDX) Stock Price Up 7.3% – Here’s Why - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

Allspring Global Investments Holdings LLC Sells 19,212 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seekin - GuruFocus.com

Nov 02, 2024
pulisher
Nov 02, 2024

Ardelyx Third Quarter 2024 Earnings: US$0.003 loss per share (vs US$0.03 profit in 3Q 2023) - Yahoo Finance

Nov 02, 2024
pulisher
Nov 02, 2024

Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key Metrics - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Ardelyx (NASDAQ:ARDX) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings call: Ardelyx reports solid growth amid Medicare challenges - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings call: Ardelyx reports solid growth amid Medicare challenges By Investing.com - Investing.com Canada

Nov 01, 2024
pulisher
Nov 01, 2024

Ardelyx (NASDAQ:ARDX) Shares Up 7.3%Should You Buy? - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Ardelyx Target of Unusually High Options Trading (NASDAQ:ARDX) - MarketBeat

Nov 01, 2024

Finanzdaten der Ardelyx Inc-Aktie (ARDX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):